Modified c-reactive protein is expressed by stroke neovessels and is a potent activator of angiogenesis in vitro

Brain Pathology

Volumn 20, Issue 1, 2010, Pages 151-165

  Slevin, Mark ^a,b   Matou Nasri, Sabine ^a   Turu, Marta ^b   Luque, Ana ^b,c   Rovira, Norma ^b   Badimon, Lina ^b   Boluda, Susana ^c   Potempa, Lawrence ^d   Sanfeliu, Coral ^e   De Vera, Nuria ^e   Krupinski, Jerzy ^b,c  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d Acphazin Inc   (United States)

^e INST D INVESTIGACIONS B   (Spain)

Author keywords

Angiogenesis; Ischemic stroke; Modified C reactive protein; Revascularization

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; C REACTIVE PROTEIN; ENDOGLIN; FIBROBLAST GROWTH FACTOR 2; GLUCOSE; LYMPHOCYTE ANTIGEN RECEPTOR; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MODIFIED C REACTIVE PROTEIN; OXYGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGENESIS; ANTIGEN DETECTION; ARTICLE; BRAIN INFARCTION; BRAIN REGION; CELL MIGRATION; CELL NUCLEUS; CELL SURFACE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; FOOD DEPRIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MICROVASCULATURE; NERVE CELL LESION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ANIMALS; ANOXIA; ANTIBODIES; BLOTTING, WESTERN; C-REACTIVE PROTEIN; CAPILLARIES; CATTLE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CHEMOTAXIS; ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FETUS; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE; HUMANS; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN KINASE INHIBITORS; RECEPTORS, IGG; STROKE;

EID: 71549132286     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2008.00256.x     Document Type: Article

References (44)

1. Arumugam TV, Woodruff TM, Lathia JD, Selvaraj PK, Mattson MP, Taylor SM (2008) Neuroprotection in stroke by complement inhibition and immunoglobulin therapy. Neuroscience EPub ahead of print G
2. McGlynn PW, Potempa LA, Filep JG, Labarrere CA (2007) Conduct unbecoming: CRP interactions with a broad range of protein molecules. J Heart Lung Transplant 26 : 705 713.
3. Bose A, Henkes H, Alfke K, Reith W, Mayer TE, Berlis A et al (2008) The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. Am J Neuroradiol 29 : 1409 1413.
4. Calabro P, Willerson JT, Yeh ET (2003) Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108 : 1930 1932.
5. Cirillo P, Golino P, Calabrò P, Calì G, Ragni M, De Rosa S et al (2005) C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovasc Res 68 : 47 55.
6. Ciubotaru I, Potempa LA, Wander RC (2005) Production of modified C-reactive protein in U937-derived macrophages. Exp Biol Med 230 : 762 770.
7. Dasu MR, Devaraj S, Du Clos TW, Jialal I (2007) The biological effects of CRP are not attributable to endotoxin contamination: evidence from TLR4 knockdown human aortic endothelial cells. J Lipid Res 48 : 509 512.
8. Devaraj S, Dasu MR, Singh U, Rao LV, Jialal I (2008) C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo. Atherosclerosis E-pub ahead of print EE
9. Haines GK, Radosevich JA, Potempa LA (2000) Immunohistochemical localization of mCRP antigen in normal vascular tissue. Am J Med Sci 319 : 79 83.
10. Hatanaka K, Li XA, Masuda K, Yutani C, Yamamoto A (1995) Immunohistochemical localization of C-reactive protein-binding sites in human atherosclerotic aortic lesions by a modified streptavidin-biotin-staining method. Pathol Int 45 : 635 641.
11. He Y, Chang G, Zhan S, Song X, Wang X, Luo Y (2008) Soluble tissue factor has unique angiogenic activities that selectively promote migration and differentiation but not proliferation of endothelial cells. Biochem Biophys Res Commun 370 : 489 494.
12. Jabs WJ, Theissing E, Nitschke M, Bechtel JF, Duchrow M, Mohamed S et al (2003) Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Circulation 108 : 1428 1431.
13. Ji SR, Wu Y, Potempa LA, Liang YH, Zhao J (2006) Effect of modified CRP on complement activation. A possible complement regulatory role of modified or monomeric CRP in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 26 : 935 941.
14. Ji SR, Wu Y, Potempa LA, Sheng FL, Lu W, Zhao J (2007) Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate mCRPm. FASEB J 21 : 284 294.
15. Khreiss T, Jozsef L, Potempa LA, Filep JG (2004) Conformational rearrangement in CRP is required for proinflammatory actions on endothelial cells. Circulation 109 : 2016 2022.
16. Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM (1994) Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 25 : 1794 1798.
17. Krupinski J, Stroemer P, Slevin M, Marti E, Kumar P, Rubio F (2003) Three-dimensional structure and survival of newly formed blood vessels after focal cerebral ischemia. Neuroreport 14 : 1171 1176.
18. Krupinski J, Turu MM, Martínez-González J, Carvajal A, Juan-Babot JO, Iborra E et al (2006) Endogenous expression of C-reactive protein is increased in active (ulcerated noncomplicated) human carotid artery plaques. Stroke 37 : 1200 1204.
19. Krupinski J, Slevin M, Martínez-González J (2007) Carotid plaque, pathogenesis of stroke and CRP: treatment of ischaemic stroke. Curr Treat Options Cardiovasc Med 9 : 229 235.
20. Liang YJ, Shyu KG, Wang BW, Lai LP (2006) C-reactive protein activates nuclear factor-B pathway and induces vascular cell adhesion molecule-1 expression through CD32 in human umbilical vein endothelial cells and aortic endothelial cells. J Mol Cell Cardiol 40 : 412 420.
21. Liu C, Wang S, Deb A, Nath KA, Katusic ZS, McConnell JP, Caplice NM (2005) Proapoptotic, antimigratory, antiproliferative and antiangiogenic effects of commercial C-reactive protein on various human endothelial cell types in vitro. Implications of contaminating presence of sodium azide in commercial preparation. Circ Res 97 : 135 143.
22. Mitsios N, Saka M, Krupinski J, Pennucci R, Sanfeliu C, Wang Q et al (2007) A microarray study of gene and protein regulation in human and rat brain following middle cerebral artery occlusion. BMC Neurosci 8 : 1 14, 93.
23. Mitsios N, Pennucci R, Sanfeliu C, Krupinski J, Gaffney J, Kumar P et al (2007) Over-expression and activation of cyclin-dependent kinase-5 following acute ischaemic stroke in man. Brain Pathol 17 : 11 23.
24. Molins B, Peña E, Vilahur G, Mendieta C, Slevin M, Badimon L (2008) C-Reactive protein isoforms differ in their effects on thrombus growth. J Thromb Haemost 28 : 2239 2246.
25. Montero I, Orbe J, Varo N, Beloqui O, Monreal JI, Rodriquez JA et al (2006) C-reactive protein induces matrix metalloproteinase-1 and 10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. J Am Coll Cardiol 47 : 1369 1378.
26. Nijmeijer R, Lagrand WK, Lubbers YTP, Visser CA, Meijer CJLM, Niessen HWM, Hack CE (2003) C-reactive protein activates complement in infarcted human myocardium. Am J Pathol 163 : 269 275.
27. Schwedler SB, Guderian F, Dammrich J, Potempa LA, Wanner C (2003) Tubular staining of modified C-reactive protein in diabetic chronic kidney disease. Nephrol Dial Transplant 18 : 2300 2307.
28. Schwedler SB, Amann K, Wernicke K, Krebs A, Nauck M, Wanner C et al (2005) Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice. Circulation 112 : 1016 1023.
29. Schwedler SB, Kuhlencordt PJ, Ponnuswamy PP, Hatiboglu G, Quaschning T, Widder J et al (2007) Native C-reactive protein induces endothelial dysfunction in ApoE - mice: implications for iNOS and reactive oxygen species. Atherosclerosis 195 : 76 84.
30. Slevin M, Kumar S, Gaffney J (2002) Angiogenic oligosaccharides of hyaluronan induce multiple signalling pathways affecting vascular endothelial cell mitogenic and wound healing processes. J Biol Chem 277 : 41046 41059.
31. Slevin M, Krupinski J, Kumar P, Gaffney J, Kumar S (2005) Gene activation and protein expression following ischaemic stroke: strategies towards neuroprotection. J Cell Mol Med 9 : 85 102.
32. Slevin M, Kumar P, Gaffney J, Kumar S, Krupinski J (2006) Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential. Clin Sci 111 : 171 183.
33. Slevin M, Krupinski J, Mitsios N, Perikleous C, Cuadrado E, Montaner J et al (2008) Leukaemia inhibitory factor is over-expressed by ischaemic brain tissue concomitant with reduced plasma expression following acute stroke. Eur J Neurol 15 : 29 37.
34. Smith CJ, Emsley HCA, Gavin CM, Georgiou RF, Vail A, Barberan EM et al (2004) Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurology 4 : 1 8.
35. Szeplaki G, Szegedi R, Hirschberg K, Gombos T, Varga L, Karadi I et al (2008) Strong complement activation after acute ischaemic stroke is associated with unfavorable outcomes. Atherosclerosis Epub ahead of print KE
36. Giddings JC, van den Berg CW (2005) C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide. Arterioscler Thromb Vasc Biol 25 : 1225 1230.
37. Taylor KE, van den Berg CW (2007) Structural and functional comparison of native pentameric, denatured monomeric and biotinylated C-reactive protein. Immunology 120 : 404 411.
38. Turu M, Slevin M, Matou S, West DC, Rodriguez C, Luque A et al (2008) C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression. BMC Cell Biology 9 : 1 14, 47.
39. Vaith P, Prasauskas V, Potempa LA, Peter HH (1996) Complement activation by C-reactive protein on the HEp-2 cell substrate. Int Arch Allergy Immunol 111 : 107 117.
40. Venugopal SK, Devaraj S, Jialal I (2005) Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrineautocrine effects. Am J Pathol 166 : 1265 1271.
41. Wang HW, Sui SF (2001) Dissociation and subunits rearrangement of membrane-bound human C-reactive proteins. Biochem Biophys Res Commun 288 : 75 79.
42. Yang J, Wang J, Zhu S, Chen X, Wu H, Yang D, Zhang J (2008) C-reactive protein augments hypoxia-induced apoptosis through mitochondrion-dependent pathway in cardiac myocytes. Mol Cell Biochem 310 : 215 226.
43. Yosajima K, Schwab C, McGeer G, McGreer PL (2000) Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease. Brain Res 887 : 80 89.
44. Zhong Y, Li SH, Liu SM, Szmitko PE, He XQ, Fedak PWM, Verma S (2006) C-reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells. Hypertension 48 : 504 511.